BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31740394)

  • 1. Pharmacokinetic profile of N-acetylcysteine amide and its main metabolite in mice using new analytical method.
    He R; Zheng W; Ginman T; Ottosson H; Norgren S; Zhao Y; Hassan M
    Eur J Pharm Sci; 2020 Feb; 143():105158. PubMed ID: 31740394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of free and total N-acetylcysteine amide and its metabolite N-acetylcysteine in human plasma using derivatization and electrospray LC-MS/MS.
    King B; Vance J; Wall GM; Shoup R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():25-36. PubMed ID: 30708342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and quantification of N-acetyl-l-cysteine and N-acetyl-cysteine-amide by HPLC with fluorescence detection.
    Wu W; Goldstein G; Adams C; Matthews RH; Ercal N
    Biomed Chromatogr; 2006 May; 20(5):415-22. PubMed ID: 16167305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine amide, a promising antidote for acetaminophen toxicity.
    Khayyat A; Tobwala S; Hart M; Ercal N
    Toxicol Lett; 2016 Jan; 241():133-42. PubMed ID: 26602168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC).
    Ates B; Abraham L; Ercal N
    Free Radic Res; 2008 Apr; 42(4):372-7. PubMed ID: 18404536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine.
    Sunitha K; Hemshekhar M; Thushara RM; Santhosh MS; Yariswamy M; Kemparaju K; Girish KS
    Free Radic Res; 2013 May; 47(5):357-67. PubMed ID: 23472882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells.
    Wu W; Abraham L; Ogony J; Matthews R; Goldstein G; Ercal N
    Life Sci; 2008 May; 82(21-22):1122-30. PubMed ID: 18448127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice.
    Penugonda S; Ercal N
    Toxicol Lett; 2011 Feb; 201(1):1-7. PubMed ID: 21145953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetylcysteine amide (NACA) and diNACA inhibit H
    Martis RM; Grey AC; Wu H; Wall GM; Donaldson PJ; Lim JC
    Exp Eye Res; 2023 Sep; 234():109610. PubMed ID: 37536438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of N-acetylcysteine and N-acetylcysteine amide from contact lenses.
    Atabek Yigit E; Ercal N
    Eye Contact Lens; 2013 Sep; 39(5):335-40. PubMed ID: 23945523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatment.
    Chen W; Ercal N; Huynh T; Volkov A; Chusuei CC
    J Colloid Interface Sci; 2012 Apr; 371(1):144-9. PubMed ID: 22284448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status.
    Zhou J; Coles LD; Kartha RV; Nash N; Mishra U; Lund TC; Cloyd JC
    J Pharm Sci; 2015 Aug; 104(8):2619-26. PubMed ID: 26052837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review of Human and Animal Studies Examining the Efficacy and Safety of
    Bhatti J; Nascimento B; Akhtar U; Rhind SG; Tien H; Nathens A; da Luz LT
    Front Neurol; 2017; 8():744. PubMed ID: 29387038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12.
    Penugonda S; Mare S; Goldstein G; Banks WA; Ercal N
    Brain Res; 2005 Sep; 1056(2):132-8. PubMed ID: 16120436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
    Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
    Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI.
    Pandya JD; Readnower RD; Patel SP; Yonutas HM; Pauly JR; Goldstein GA; Rabchevsky AG; Sullivan PG
    Exp Neurol; 2014 Jul; 257():106-13. PubMed ID: 24792639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N-Acetylcysteine and N-Acetylcysteine Amide on Erythrocyte Deformability and Oxidative Stress in a Rat Model of Lower Extremity Ischemia-Reperfusion Injury.
    Erol G; Kartal H; Comu FM; Cetin E; Demirdas E; Sicim H; Unal CS; Gunay C; Oz BS; Bolcal C
    Cardiol Res Pract; 2020; 2020():6841835. PubMed ID: 33062321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of N-acetylcysteine amide on experimental focal penetrating brain injury in rats.
    Günther M; Davidsson J; Plantman S; Norgren S; Mathiesen T; Risling M
    J Clin Neurosci; 2015 Sep; 22(9):1477-83. PubMed ID: 26100161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and reversal of selenite-induced cataracts by N-acetylcysteine amide in Wistar rats.
    Maddirala Y; Tobwala S; Karacal H; Ercal N
    BMC Ophthalmol; 2017 Apr; 17(1):54. PubMed ID: 28446133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Thioester Prodrug of N-acetylcysteine for Odor Masking and Bioavailability Enhancement.
    Bhilare NV; Dhaneshwar SS; Sinha AJ; Kandhare AD; Bodhankar SL
    Curr Drug Deliv; 2016; 13(4):611-20. PubMed ID: 26338258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.